濮阳东方男科医院导航(濮阳东方医院男科割包皮收费很低) (今日更新中)

BEIJING, Aug. 16 (Xinhuanet) -- It is widely accepted that obesity leads to an increased risk of health complications, but new studies quoted by media Tuesday challenge the conventional notion.“Our studies challenge the idea that all obese individuals need to lose weight,” said Dr. Jennifer Kuk, assistant professor in York University’s School of Kinesiology & Health Science in Toronto.  One of the studies used data from the Aerobics Center Longitudinal Study consisting of 29,533 individuals and assessed their mortality in 16 years.It found no difference in death risks between normal-weight individuals and obese ones. "Since the obese people did not have greater risk of dying than normal weight individuals, they don’t need to lose weight," said Dr. Kuk.But the finding did not give obese individuals a “free license” to gain weight, Dr. Kuk added. Maintaining weight, eating right and exercising may be better than trying to lose weight in the long run, said Dr. Kuk.

BEIJING, Sept. 6 (Xinhuanet) -- NASA will launch on Thursday twin lunar orbiters built to map the gravity of Earth's moon in unprecedented detail, media reported Tuesday.The twin lunar probes, Graili-A and Graili-B, will blast off from Florida's Cape Canaveral Air Force Station at 8:37 a.m. EDT and at 9:16 a.m. EDT respectively Thursday, according to NASA.The Grail twins will travel three to four months to get to the moon under a slower but more economical plan.Artist concept of GRAIL mission. Grail will fly twin spacecraft in tandem orbits around the moon for several months to measure its gravity field in unprecedented detail.The two spacecrafts will reach the moon around New Year's Day when they will begin to probe the moon's composition from the crust to the core, according to NASA.The data collected by the probes will be used to better understand the moon's evolution and formation, NASA scientists said.Researchers will also use the twin probes to pinpoint the best landing sites for future explorations.The mission, from start to finish, costs 496 million U.S. dollars. The two Grail probes will crash into the moon after its mission.

BEIJING, Aug. 1 (Xinhua) -- The provinces of Guizhou and Hunan reported their lowest levels of precipitation since 1951 in July, the China Meteorological Administration (CMA) said on Monday.Precipitation levels across the country saw a decrease of 8.7 percent from the average level of 115.9 mm in July, the lowest levels seen in 11 years, said Chen Zhenlin, an expert with the CMA.The average temperature recorded across the country in July was 22.1 degrees Celsius, up 0.7 degrees Celsius from the average level.

BEIJING, June 12 (Xinhua) -- China's Supreme People's Court (SPC) on Sunday publicized a judicial interpretation which sets specific rules for the country's courts to order penalties to criminals sabotaging TV and radio facilities.The interpretation said that criminals, whose sabotage causes information block for disaster early warning, rescue and others concern public security, could be convicted three to seven years of imprisonment on the charge of sabotaging TV and radio broadcast facilities.Other circumstances that could be convicted the imprisonment include sabotage that causes malfunction in the broadcast of TV and radio stations, according to the new law.According to statistics with the SPC, there have been more than 5,000 cases of sabotaging cable TV wires and more than 1,000 cases of sabotaging state-owned fiber optic lines and other cases of stealing broadcast facilities since 2006 in China.

BEIJING, July 26 (Xinhuanet) -- Seven of the 20 top selling American prescription drugs will lose their patents by the end of next year, making way for less expensive generic versions, according to media reports.It's a shift that could save consumers billions of dollars -- assuming those big-ticket medications are willing to give up a trusted brand name for an off-label replacement.The prices of medications such as cholesterol-fighting Lipitor and blood thinner Plavix are expected to go down significantly, according to the U.S. Food and Drug Administration (FDA).Lipitor will lose its patent in November. When that patent expires, people are advised to buy atorvastatin, the generic equivalent. Other brand names include the anti-psychotic Zyprexa and the rheumatoid arthritis and psoriasis drug Enbrel, of which the patent will expire in October and October of next year, respectively.Over the next 10 years, an estimated 120 more brand-name prescription drugs will lose their patents in the U.S.

来源：资阳报